参考文献/References:
[1] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of inci-dence and mortality worldwide for 36 cancers in 185 countries[J]. CA-A Cancer Journal for Clinicians, 2021, 71(3): 209-249.
[2] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志, 2024, 46(3): 221-231. ZHENG R S, CHEN R, HAN B F, et al. Cancer inci-dence and mortality in China, 2022[J]. Chinese Journal of Oncology, 2024, 46(3): 221-231.
[3] ZAUBER A G, WINAWER S J, O’BRIEN M J, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths[J]. New England Journal of Medicine, 2012, 366(8): 687-696.
[4] 杨婷,董泽华,李佳,等.结直肠黏膜癌前状态及癌前病变内镜下随访策略[J].中华消化杂志, 2024, 44(7):483-486. YANG T, DONG Z H, LI J, et al. Endoscopic follow-up strategies for colorectal precancerous conditions and precancerous lesions[J]. Chinese Journal of Digestion, 2024, 44(7): 483-486.
[5] JIANG T, GRADUS J L, LASH T L, et al. Addressing measurement error in random forests using quantitative bias analysis[J]. American Journal of Epidemiology, 2021, 190(9): 1830-1840.
[6] EMMANUEL T, MAUPONG T, MPOELENG D, et al. A survey on missing data in machine learning [J]. Jour-nal of Big Data, 2021, 8(1): 140.
[7] 郝晓燕,周磊,白丛霞,等.基于机器学习方法建立血清多种肿瘤标志物联合区分胃炎和胃癌的三种模型及评价[J].现代检验医学杂志, 2023, 38(2): 124-128. HAO X Y, ZHOU L, BAI C X, et al. Establishment and evaluation of three models for the distinguish gastritis and gastric cancer with multiple serum tumor markers based on machine learning methods[J]. Journal of Mod-ern Laboratory Medicine, 2023, 38(2): 124-128.
[8] BARTLETT P L, LONG P M, LUGOSI G, et al. Be-nign overfitting in linear regression[J]. Proceedings of the National Academy of Sciences of the United States of American, 2020, 117(48): 30063-30070.
[9] 李丹,汪嵘.结直肠癌肠镜筛查参检率影响因素研究[J].肿瘤研究与临床, 2024, 36(7): 557-560. LI D, WANG R. Factors influencing the participation rate in colorectal cancer screening by colonoscopy[J]. Cancer Research and Clinic, 2024, 36(7): 557-560.
[10] 李怡玲,关旭,窦利州,等.粪便多靶点DNA与粪便潜血联合检测技术对结直肠癌早诊早筛的诊断价值分析[J].中华医学杂志, 2022, 102(33): 2607-2613. LI Y L, GUAN X, DOU L Z, et al. The clinical value of multi-target stool fecal immunochemical test-DNA in early screening and diagnosis for colorectal cancer[J]. National Medical Journal of China, 2022, 102(33): 2607-2613.
[11] 朱小伶,贺雪,刘雪莲,等.品管圈在降低体检中心大便检查弃检率中的效果[J].当代护士, 2018, 25(32):176-177. ZHU X L, HE X, LIU X L, et al. The effect of Quality Control Circle in reducing the abandonment rate of stool tests in the physical examination center[J]. Mod-ern Nurse, 2018, 25(32): 176-177.
[12] ZUO D, YANG L X, JIN Y, et al. Machine learn-ing-based models for the prediction of breast cancer recurrence risk[J]. BMC Medical Informatics and Deci-sion Making, 2023, 23(1): 276.
[13] XIONG Y B, MA Y, RUAN L G, et al. Comparing different machine learning techniques for predicting COVID-19 severity[J]. Infectious Diseases of Poverty, 2022, 11(1): 19.
[14] ZAREI GHOBADI M, AFSANEH E, EMAMZADEH R. Gene biomarkers and classifiers for various subtypes of HTLV-1-caused ATLL cancer identified by a com-bination of differential gene co-expression and support vector machine algorithms[J]. Medical Microbiology and Immunology, 2023, 212(4): 263-270.
[15] LIANG D, WANG L, ZHONG P P, et al. Perspective:global burden of iodine deficiency: insights and projec-tions to 2050 using XGBoost and SHAP [J]. Advances in Nutrition, 2025, 16(3): 100384.
[16] ZHANG L, YE J, LUO Q Y, et al. Prediction of poor outcomes in patients with colorectal cancer: elevated preoperative prothrombin time (PT) and activated par-tial thromboplastin time (APTT) [J]. Cancer Manage-ment and Research, 2020, 12: 5373-5384.
[17] LEBLANC R, PEYRUCHAUD O. Metastasis: new functional implications of platelets and megakaryo-cytes[J]. Blood, 2016, 128(1): 24-31.
[18] CHEN Z J, VONG C T, GAO C F, et al. Bilirubin nano-medicines for the treatment of reactive Oxygen species (ROS)-Mediated diseases[J]. Molecular Pharmaceutics, 2020, 17(7): 2260-2274.
[19] WU E, WEI G F, LI Y, et al. Serum urea concentration and risk of 16 site-specific cancers, overall cancer, and cancer mortality in individuals with metabolic syn-drome: a cohort study[J]. BMC Medicine, 2024, 22(1):536.
[20] POKU L O, PHIL M, CHENG Y N, et al. 23Na-MRI as a noninvasive biomarker for cancer diagnosis and prognosis [J]. Journal of Magnetic Resonance Imaging, 2021, 53(4): 995-1014.
[21] 张颖.结直肠癌患者血清SDC4,CXCL1水平检测在临床诊断及淋巴结转移评估中的应用价值[J].现代检验医学杂志, 2025, 40(1): 116-121. ZHANG Y. Application value of serum SDC4,CXCL1 level detection in clinical diagnosis and lymph node me-tastasis assessment in colorectal cancer patients[J]. Journal of Modern Laboratory Medicine, 2025, 40(1): 116-121.
[22] 付超英,黄士月,张云霞.直肠癌组织中LncRNA TTN-AS1及角鲨烯环氧酶表达与临床病理特征及预后相关性研究[J].现代检验医学杂志, 2024, 39(5):12-16, 53. FU C Y, HUANG S Y, ZHANG Y X. Correlation between the expression of LncRNA TTN-AS1 and squalene epoxidase in rectal cancer tissue and clinico-pathological characteristics and prognosis[J]. Journal of Modern Laboratory Medicine, 2024, 39(5): 12-16, 53.